RT Journal Article
SR Electronic
T1 The Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody–associated Vasculitis
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.181351
DO 10.3899/jrheum.181351
A1 Alvise Berti
A1 Eric L.  Matteson
A1 Cynthia S.  Crowson
A1 Ulrich Specks
A1 Divi Cornec
YR 2019
UL http://www.jrheum.org/content/early/2019/06/24/jrheum.181351.abstract
AB We read with interest in The Journal of Rheumatology the article by Kang, et al, “High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis,”1 which reported a dramatically high incidence of arterial (ATE) and venous thrombosis events (VTE) in a hospital-based cohort of patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). The study generally supports the previously reported increased risk of ATE and VTE in patients affected by AAV2–8, but has a number of inaccuracies and methodological issues that inflate the incidence rates of ATE and VTE.